Arcutis Share Price

Arcutis Share Price

NASDAQ: ARQT | Mid Cap | Healthcare
$27.52
+$0.17 (0.62%) Last updated on 19 Nov, 2026 | 01:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Arcutis Stock Performance

Open
$27.48
Prev. Close
$27.35
Circuit Range
N/A
Day Range
$27.25 - $27.75
Year Range
$19.30 - $34.79
Volume
29,844
Average Traded
$27.53

Arcutis Share Price Today

As of 19 November 2026, Arcutis Biotherapeutics, Inc.'s share price is $27.52. The stock opened at $27.48, compared to its previous close of $27.35. During today's trading session, Arcutis Biotherapeutics, Inc.'s share price traded between $27.25 and $27.75, with an average price of $27.50. Over the past 52 weeks, the stock has recorded a high of $34.79 and a low of $19.30. In terms of performance, Arcutis Biotherapeutics, Inc.'s share price has risen by 28.12% over the last six months and is down 10.23% on a year-on-year basis.

Arcutis Share Price Chart

Line chart of the Arcutis price trend over the selected period. The price rose overall, ranging from 27.28 to 27.75, ending at 27.52.
$27.25$27.75
L
Show Current Price
H

Arcutis Stock Fundamentals & Key Indicators

Market Cap
$3.50B
PE Ratio (TTM)
115.55
Dividend Yield
0.00%
EPS (TTM)
$0.24
Revenue (TTM)
$376.07B
Return On Equity (TTM)
12.26%
Profit Margin
-4.29%
Debt to Equity
0.45
Quarterly Earnings Growth YoY
-49.43%

Arcutis Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$129.50$105.40$129.86$143.92
Net Profit$17.40-$11.30$15.01$8.80
Net Profit Margin13.44%-10.72%11.56%6.11%
Income ChangeN/A-164.94%232.83%-41.37%

Arcutis Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$3.69$59.61$196.54$376.07
Net Profit-$311.46-$262.14-$140.04-$16.14
Net Profit Margin-8440.65%-439.76%-71.25%-4.29%
Income ChangeN/A15.84%46.58%88.47%

Arcutis Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets21.7413.0710.9311.87
Current Assets411.23335.82330.43437.41
Total Assets432.97348.89341.37449.27
Non Current Liabilities113.66110.34206.03201.89
Current Liabilities129.8481.0146.6737.81
Total Liabilities243.49191.35252.7239.69
Shareholders' Equity189.48157.5488.67209.58

Arcutis Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-5.63-112.16-247.06-257.72
Investing-30.2528.82180.23-87.2
Financing6.9766.2101.32301.8

About Arcutis

Arcutis Biotherapeutics Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing treatments for dermatological diseases with high unmet medical needs. Its current portfolio is comprised of differentiated topical and systemic treatments with potential to treat immune-mediated dermatological diseases and conditions. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population. The Company has one reportable segment relating to the development and commercialization of treatments for dermatological diseases.

Arcutis Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$31.93
$27.55
-13.91%
Oct 2026
$26.07
$32.00
+20.92%
Sep 2026
$24.00
$26.46
+6.41%
Aug 2026
$26.39
$24.86
-7.41%
Jul 2026
$26.35
$26.86
+2.30%
Jun 2026
$21.30
$26.25
+22.21%
May 2026
$23.12
$21.48
-7.45%
Apr 2026
$23.80
$23.21
-1.55%
Mar 2026
$25.90
$23.57
-12.59%
Feb 2026
$25.02
$26.97
+6.18%
Jan 2026
$28.89
$25.40
-12.53%
Dec 2025
$30.14
$29.04
-5.27%

Arcutis Share Price FAQs